Health systems have no shortage of successful AI pilots. Ambient documentation, revenue cycle automation, clinical decision support — individual use cases have delivered real results in individual ...
Solana’s role in crypto has shifted considerably over the past two years. It was once mostly a high-throughput Ethereum ...
UiPath has announced what it describes as the first enterprise automation platform with native support for multiple AI coding agents, including OpenAI Codex and Anthropic’s Claude Code. The new ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
UiPath's latest product session was billed as an investor briefing, but the most consequential announcement was a pivot in who - or what - the platform is actually built for. Most enterprise AI ...
Let's be honest, we're all drama queens sometimes. Whether you're texting your bestie you're “literally dying” over the latest celebrity gossip or declaring on social media that Monday mornings are ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced a new security automation capability, built in collaboration with Microsoft, to help ...
UiPath has been doing well within its existing customer base, and that continued in the fourth quarter of fiscal year 2026, ended Jan. 31, with the company reporting a 107% dollar-based net retention ...
UiPath PATH0.63%increase; green up pointing triangle reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year ...
UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% ...
UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...